ACCD Jul 2023 10.000 call
| Previous Close | 2.5000 |
| Open | 1.9000 |
| Bid | 1.3000 |
| Ask | 2.2000 |
| Strike | 10.00 |
| Expire Date | 2023-07-21 |
| Day's Range | 1.9000 - 1.9000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 15 |
- Investing.com
4 big analyst picks: NVIDIA upgraded after crushing estimates
Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: upgrades at NVIDIA, Ford, Vipshop, and Accolade. Baird upgraded NVIDIA (NASDAQ:NVDA) to Outperform from Neutral and raised its price target to $475.00 from $300.00.
ZacksAccolade (ACCD) Upgraded to Buy: What Does It Mean for the Stock?
Accolade (ACCD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
GlobeNewswireAccolade Announces Upcoming Investor Events
SEATTLE, May 08, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the following upcoming investor events. A webcast and replay of each event will be available at ir.accolade.com. Monday, May 8 at 1:00 pm PT. Accolade’s Capital Markets Day at the Wynn Las VegasTuesday, May 9 at 3:40 pm PT. BofA Securities Health Care Conference 2023 at the Encore Hotel in Las Vegas About Accolade, Inc. Acco
Simply Wall St.Accolade Full Year 2023 Earnings: In Line With Expectations
Accolade ( NASDAQ:ACCD ) Full Year 2023 Results Key Financial Results Revenue: US$363.1m (up 17% from FY 2022). Net...
ZacksAccolade (ACCD) Reports Q4 Loss, Misses Revenue Estimates
Accolade (ACCD) delivered earnings and revenue surprises of 2.33% and 0.62%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2023
Fiscal fourth quarter 2023 revenue of $99.0 million, a 6% increase compared to fiscal fourth quarter 2022 revenue of $93.8 million Fiscal year 2023 revenue of $363.1 million, a 17% increase compared to fiscal 2022 revenue of $310.0 million SEATTLE, April 27, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 28, 2023. “Fiscal year 2023 marked a transformational time for Accolade, as we tightly integr
- GlobeNewswire
Accolade to Webcast Analyst Day on May 8, 2023
SEATTLE, April 24, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will host an Analyst Day at the Wynn Las Vegas on May 8, 2023 and will provide a webcast of the event beginning at 1pm PT. Members of Accolade’s management team will provide color about the Company’s long term vision, as well as key insights about its overall product, clinical, ecosystem and financial strategy. The webcast will be hosted at ir.
- Simply Wall St.
Accolade, Inc.'s (NASDAQ:ACCD) high institutional ownership speaks for itself as stock continues to impress, up 9.4% over last week
Key Insights Significantly high institutional ownership implies Accolade's stock price is sensitive to their trading...
- GlobeNewswire
Accolade to Announce Fiscal Fourth Quarter 2023 Financial Results
SEATTLE, April 11, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal fourth quarter 2023 financial results on Thursday, April 27, 2023, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-reg
ZacksSprinkler (CXM) Q4 Earnings and Revenues Top Estimates
Sprinkler (CXM) delivered earnings and revenue surprises of 200% and 1.61%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Increasing losses over year doesn't faze Accolade (NASDAQ:ACCD) investors as stock hikes 14% this past week
It is doubtless a positive to see that the Accolade, Inc. ( NASDAQ:ACCD ) share price has gained some 63% in the last...
- Investing.com
5 analyst picks of the day: Nike upped on Q3 beat | Pro Recap
Barclays upgraded Nike (NYSE:NKE) to Overweight from Equalweight and raised its price target to $154.00 from $110.00 on its belief in a high probability of margin upside. The company reported its Q3 earnings results on Tuesday, which, according to Barclays, demonstrated the company’s “broad-based brand strength in spite of a weakening consumer macro backdrop.” Q3 EPS came in at $0.79, better than the consensus estimate of $0.55.
- Simply Wall St.
Should You Investigate Accolade, Inc. (NASDAQ:ACCD) At US$13.30?
Accolade, Inc. ( NASDAQ:ACCD ), might not be a large cap stock, but it received a lot of attention from a substantial...
- Simply Wall St.
An Intrinsic Calculation For Accolade, Inc. (NASDAQ:ACCD) Suggests It's 31% Undervalued
How far off is Accolade, Inc. ( NASDAQ:ACCD ) from its intrinsic value? Using the most recent financial data, we'll...
- GlobeNewswire
Michael Hilton Joins Accolade Board of Directors
Co-founder of Concur joins Board after serving as the Company’s CIOSEATTLE, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced changes to its Board of Directors. The Company announced today that long-time executive Michael Hilton will step down from his operating role at the Company to join the Board of Directors, replacing Tom Neff, who has served on Accolade’s Board since 2010. “Michael has been instrumental in helping Accolade reshape how healthcare is experienced
- Simply Wall St.
With stock up 14%, Insiders of Accolade, Inc. (NASDAQ:ACCD) must be wishing they had bought more last year
Accolade, Inc. ( NASDAQ:ACCD ) insiders who purchased shares in the last 12 months were richly rewarded last week. The...
Motley FoolWhy Shares of Accolade Soared This Week
Shares of Accolade (NASDAQ: ACCD) were up as much as 25% for the week early Friday, according to data provided by S&P Global Market Intelligence. The independent health benefits navigator announced third-quarter earnings on Monday. Accolade reported revenue of $90.9 million, up 9% year over year, and a net income loss of $39.9 million, compared to positive net income of $22.5 in the same period a year ago.
ZacksAccolade (ACCD) Reports Q3 Loss, Tops Revenue Estimates
Accolade (ACCD) delivered earnings and revenue surprises of 8.20% and 4.43%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Accolade Announces Results for Fiscal Third Quarter 2023
Fiscal third quarter 2023 revenue of $90.9 million, a 9% increase compared to fiscal third quarter 2022 revenue of $83.5 million SEATTLE, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2022. “Accolade enters the new year having just concluded one of the strongest selling performances in our company’s history. Notably, the strength in our business is driven by the increasing diversity in our platfor
- GlobeNewswire
Accolade Announces Participation in 25th Annual Needham Growth Conference
SEATTLE, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the 25th Annual Needham Growth Conference on Wednesday, January 11, 2023 and will host a fireside chat at 1:30 pm ET. A webcast and replay of the fireside chat will be available at ir.accolade.com. About Accolade, Inc. Accolade (Nasdaq: ACCD) provides millions of people and their families with an exceptional healthcare experience that is personal, data driven and value based to he
- GlobeNewswire
Accolade to Announce Fiscal Third Quarter 2023 Financial Results
SEATTLE, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal third quarter 2023 financial results on Monday, January 9, 2023, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-regist
ZacksBraze, Inc. (BRZE) Moves 5.5% Higher: Will This Strength Last?
Braze, Inc. (BRZE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- Simply Wall St.
Accolade (NASDAQ:ACCD) investors are sitting on a loss of 70% if they invested a year ago
While it may not be enough for some shareholders, we think it is good to see the Accolade, Inc. ( NASDAQ:ACCD ) share...